Skip to main content
REPL logo

Replimune Group, Inc.

REPLNASDAQHealthcareBiotechnology

$12.47Today:- (-)1Y +42.40%

As of Oct 26, 2026 close

Market cap
$1.21B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.50$16.33
Volume (live)
-
Avg. volume (3M)
1.96M

Replimune Group (REPL) Financial Ratios

For fiscal 2026 (fiscal year ended Mar 31, 2026), Replimune Group had return on equity of -107.9% (down from -62.6%), debt-to-equity of 0.67 (up from 0.18), a current ratio of 4.79 (down from 7.95) and return on assets of -45.0% (down from -31.3%). A current ratio of 4.79 means current assets exceed current liabilities.

Replimune Group Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Period endingMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Valuation Ratios
P/E Ratio------17.43
P/B Ratio3.801.811.341.801.952.85
Price/Tangible Book3.801.811.341.801.952.83
Price/FCF------22.28
Price/OCF------23.14
Enterprise Value Ratios
EV/EBITDA------12.45
EV/EBIT------12.19
EV/FCF------15.28
Profitability & Returns
Return on Equity (ROE)-107.88%-62.58%-46.42%-36.06%-25.94%-23.70%
Return on Assets (ROA)-45.02%-31.26%-25.66%-19.65%-14.33%-20.58%
Return on Invested Capital (ROIC)------141.94%
Return on Capital Employed (ROCE)-116.10%-53.10%-52.10%-28.40%-26.10%-21.30%
Leverage & Solvency Ratios
Debt/Equity0.670.180.200.110.080.06
Debt/EBITDA------0.42
Debt/FCF------0.52
Liquidity Ratios
Current Ratio4.797.9510.7217.5219.4633.25
Quick Ratio4.657.8210.5317.3319.3132.95
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-49.70%-32.93%-43.03%-17.42%-14.73%-5.74%
FCF Yield-45.05%-26.49%-38.11%-13.02%-10.54%-4.49%
Buyback Yield-15.19%-21.02%-14.36%-11.49%-12.89%-34.99%
Total Return------34.99%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Replimune Group Financial Ratios

What is Replimune Group's return on equity?

Replimune Group's return on equity (ROE) was -107.9% for fiscal 2026 (period ended Mar 31, 2026). It was -62.6% a year earlier.

What is Replimune Group's debt-to-equity ratio?

Replimune Group's debt-to-equity ratio was 0.67 for fiscal 2026 (period ended Mar 31, 2026). It was 0.18 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition